Pratibha Khanduri, Ph.D., is counsel in Sterne Kessler’s Biotechnology & Chemical Practice Group. Pratibha’s practice focuses on biotechnology, pharmaceutical, and chemical industries, and she is involved in all areas of patent procurement, exploitation, and enforcement. Pratibha has experience in patentability, validity, and infringement analyses of patents; post-grant proceedings before the Patent Trial and Appeal Board at the USPTO; and litigation, including cases involving Abbreviated New Drug Applications (ANDAs). Pratibha also has experience in freedom-to-operate analyses and patent prosecution.

Prior to joining Sterne Kessler, Pratibha was a law clerk and technical advisor at an intellectual property law firm. During law school, Pratibha was a judicial extern for the Honorable James P. Flannery at the Illinois Circuit Court of Cook County, Chicago and served as an associate editor for the Chicago-Kent Journal of Intellectual Property. In addition, Pratibha received the CALI award for the highest grade in Mediation and in International Intellectual Property Law.

Pratibha’s doctoral research focused on the role of p53 in the development and treatment of malignant melanomas. Pratibha’s primary technical areas include molecular biology, biochemistry, cancer biology, immunology, biologics, chemicals and pharmaceuticals, and clean technology.

Pratibha received her J.D. from the Chicago-Kent College of Law. She earned her Ph.D. in molecular genetics from the University of Illinois at Chicago and her Masters in biotechnology and her B.Sc. (Hons.) in human biology with Biochemistry major from the All India Institute of Medical Sciences.

  • J.D., Chicago-Kent College of Law
  • Ph.D., Molecular Genetics, University of Illinois at Chicago
  • M.S., Biotechnology, All India Institute of Medical Sciences
  • B.Sc. (Hons.), Human Biology, Biochemistry Major, All India Institute of Medical Sciences

  • District of Columbia
  • Illinois
  • United States Patent & Trademark Office

  • American Intellectual Property Law Association

Related Resources

From Pratibha Khanduri, Ph.D.

Client Alert

November 17, 2023

USPTO Confirms Different Frameworks for Pre-AIA and Post-AIA Prior-Art Determinations

Pratibha Khanduri, Ph.D.

Client Alert

March 7, 2022

IP Hot Topic: 2021 PTAB Year in Review: Analysis & Trends

Pratibha Khanduri, Ph.D.

Reports

March 7, 2022

2021 PTAB Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox Multiple Authors

Bylined Articles

March 7, 2022

A Niche Within a Niche: The PTAB’s Evolving Motion to Amend Practice

Sterne, Kessler, Goldstein & Fox Multiple Authors

Press Release

March 7, 2022

Sterne Kessler Publishes 2021 PTAB Year in Review: Analysis & Trends Report

Sterne, Kessler, Goldstein & Fox Multiple Authors

Press Release

October 8, 2020

Sterne Kessler Client Wins 2020 Nobel Prize in Chemistry for CRISPR-Cas9 Technology

Sterne, Kessler, Goldstein & Fox P.L.L.C. Multiple Authors

PTAB Strategies and Insights

December 31, 2019

PTAB Strategies and Insights - December 2019

Pratibha Khanduri, Ph.D., R. Wilson “Trey” Powers III, Ph.D.

Bylined Articles

December 31, 2019

PTAB Precedential Opinion Panel Clarifies the Standard for Establishing a Reference as a Printed Publication at Institution

Sterne, Kessler, Goldstein & Fox Pratibha Khanduri, Ph.D.

Client Alert

July 29, 2019

IP Hot Topic: USPTO Releases a Second Update to the PTAB Trial Practice Guide

Pratibha Khanduri, Ph.D.

PTAB Strategies and Insights

January 17, 2018

PTAB Strategies and Insights - January 2018

Multiple Authors

Bylined Articles

January 17, 2018

Notice - It's What's Required

Sterne, Kessler, Goldstein & Fox Jason D. Eisenberg, Pratibha Khanduri, Ph.D.

Bylined Articles

March 9, 2016

AIA Post-Grant Trial Proceedings: Three Important Developments to Watch

MSBA Bar Bulletin Pratibha Khanduri, Ph.D., Gaby L. Longsworth, Ph.D.

Firm Announcements

August 16, 2015

Claims Unpatentable for Obviousness in Final Written Decision IPR2014-00402 – Butamax Advanced Biofuels v. Gevo

The National Law Review Pratibha Khanduri, Ph.D., Gaby L. Longsworth, Ph.D.

Bylined Articles

July 13, 2015

Kimble v. Marvel – Supreme Court quiets criticism of per se rule against post-patent royalties

IP Watchdog Jeremiah B. Frueauf, Pratibha Khanduri, Ph.D.

Client Alert

June 24, 2015

Practice Considerations Post Kimble v. Marvel

Jeremiah B. Frueauf, Pratibha Khanduri, Ph.D.

Bylined Articles

June 5, 2015

Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.: Differing Standards of Appellate Review of Claim Construction

Maryland State Bar Association IP Section Pratibha Khanduri, Ph.D., Gaby L. Longsworth, Ph.D.

Bylined Articles

March 15, 2015

FOCUS: Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.

Maryland Bar Bulletin Gaby L. Longsworth, Ph.D., Pratibha Khanduri, Ph.D.